Cinctive Capital Management’s Globus Medical GMED Stock Holding History

Cinctive Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,138	Closed	-$1.91M	–	374
2024 Q4	$1.91M	Buy	+23,138	New	+$1.82M	0.1%	222
2024 Q1	–	Sell	-16,345	Closed	-$871K	–	442
2023 Q4	$871K	Buy	+16,345	New	+$797K	0.06%	262
2023 Q2	–	Sell	-105,017	Closed	-$5.95M	–	416
2023 Q1	$5.95M	Buy	+105,017	New	+$6.73M	0.2%	179
2021 Q4	–	Sell	-88,054	Closed	-$6.75M	–	581
2021 Q3	$6.75M	Buy	88,054 +38,453	+78%	+$3.09M	0.33%	83
2021 Q2	$3.85M	Buy	+49,601	New	+$3.53M	0.18%	179
2020 Q1	–	Sell	-54,108	Closed	-$3.19M	–	234
2019 Q4	$3.19M	Buy	+54,108	New	+$2.94M	0.33%	129

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cinctive Capital Management's GMED Position: Q1 2025 in Review

Cinctive Capital Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 23,138 shares — an estimated $1.91M sold.

Cinctive Capital Management first reported a position in GMED in Q4 2019 and held it in 6 quarters. The position peaked at $6.75M in Q3 2021. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Cinctive Capital Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Cinctive Capital Management sold 23,138 Globus Medical shares in Q1 2025, an estimated $1.91M.
Cinctive Capital Management first reported a position in Globus Medical in Q4 2019 and held it in 6 quarters.
Cinctive Capital Management's Globus Medical position peaked at $6.75M in Q3 2021.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Cinctive Capital Management's 13F filing for Q1 2025, filed 15 May 2025.